Marijuana, Inc. (MAJI)
0.0065
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Marijuana Shareholders Equity (Quarterly) : 13.49M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.49M |
| March 31, 2026 | 13.38M |
| September 30, 2025 | -0.4812M |
| June 30, 2025 | -0.4801M |
| March 31, 2025 | -0.6593M |
| October 31, 2024 | |
| July 31, 2024 | 1.309M |
| April 30, 2024 | 1.31M |
| January 31, 2024 | 1.313M |
| October 31, 2023 | 3.373M |
| July 31, 2023 | 3.343M |
| April 30, 2023 | 1.955M |
| January 31, 2023 | -0.0267M |
| October 31, 2022 | -0.0214M |
| July 31, 2022 | -0.0024M |
| April 30, 2022 | -0.0018M |
| January 31, 2022 | 0.0007M |
| October 31, 2021 | -0.4448M |
| July 31, 2021 | -0.4448M |
| April 30, 2021 | -0.1601M |
| January 31, 2021 | -0.4446M |
| October 31, 2020 | -15.05M |
| July 31, 2020 | -0.4633M |
| April 30, 2020 | -0.3865M |
| January 31, 2020 | -0.2187M |
| Date | Value |
|---|---|
| October 31, 2019 | -0.0417M |
| July 31, 2019 | -0.011M |
| April 30, 2019 | -0.2143M |
| January 31, 2019 | -0.1711M |
| October 31, 2018 | -0.1443M |
| July 31, 2018 | |
| April 30, 2018 | |
| January 31, 2018 | |
| October 31, 2017 | |
| July 31, 2017 | |
| April 30, 2017 | |
| January 31, 2017 | |
| October 31, 2016 | |
| July 31, 2016 | |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | |
| April 30, 2015 | |
| January 31, 2015 | |
| October 31, 2014 | |
| July 31, 2014 | |
| April 30, 2014 | |
| January 31, 2014 | |
| October 31, 2013 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 303.90M |
| BioRestorative Therapies, Inc. | 3.026M |
| Astrana Health, Inc. | 830.22M |
| U.S. Stem Cell, Inc. | -- |
| CareDx, Inc. | 425.60M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.36M |
| Total Liabilities (Quarterly) | 0.873M |
| Debt to Equity Ratio | 0.0038 |
| Current Ratio | 22.63 |
| Net Debt Paydown Yield | -2.36% |